Amarantus Bioscience Holdings Inc (AMBS)

[Goldstrike]

Sooner than many may think....
From your provided link to the University of Miami article: "“With interim toxicology data now in hand, and with multiple data sets forthcoming in the third and fourth quarter for the MANF ophthalmology program focused initially on Retinitis pigmentosa, we believe now is the ideal time to exercise our option and move forward under the auspices of a full license agreement,' said Gerald E. Commissiong, president and CEO of Amarantus."